Haemonetics Corporation Announces Third Quarter Fiscal 2026 Financial Results Available on Investor Relations Website

Financial release and supplemental presentation accessible online

Haemonetics Corporation (NYSE: HAE) announced that financial results for its third quarter fiscal year 2026, which ended December 27, 2025, are available on the Company’s Investor Relations website at www.haemonetics.com.

The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at 8:00 a.m. ET on February 5, 2026.

Conference Call and Webcast Information:


Registration: Click here to register. Upon registration, participants will receive dial-in details and a personalized PIN. While not required, joining 10 minutes prior to the event start time is recommended.


Live webcast: Access here or through the Investor Relations section of the Haemonetics website.

A replay of the conference call and webcast will be available beginning at 11:00 a.m. ET on February 5, 2026 and will remain accessible for one year via the webcast link above.

Earnings Materials:
Haemonetics has also posted the following materials on its Investor Relations website, which will be referenced during the conference call and webcast:


Third Quarter Fiscal 2026 Earnings Release


Third Quarter Fiscal 2026 Supplemental Earnings Presentation

ABOUT HAEMONETICS

Haemonetics is a global medical technology company dedicated to improving the quality, effectiveness and efficiency of health care. Our innovative solutions addressing critical medical needs include a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers; and products to enable blood centers to collect in-demand blood components. To learn more about Haemonetics, visit www.haemonetics.com.



          Investor Contacts:



 Olga Guyette, Vice President-Investor Relations & Treasury   David Trenk, Manager-Investor
                                                                Relations



 (781) 356-9763
 (203) 733-4987




          olga.guyette@haemonetics.com




          david.trenk@haemonetics.com




          Media Contact:



 Josh Gitelson, Sr. Director-Global Communications



 (781) 356-9776




          josh.gitelson@haemonetics.com


View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-corporation-announces-third-quarter-fiscal-2026-financial-results-available-on-investor-relations-website-302679292.html

SOURCE Haemonetics Corporation

https://rt.newswire.ca/rt.gif?NewsItemId=NE78738&Transmission_Id=202602050600PR_NEWS_USPR_____NE78738&DateId=20260205

comtex tracking

COMTEX_472941366/1005/2026-02-05T05:59:52

Scroll to Top